Bio-Rad Laboratories, Inc. (BIO) vs Tempus AI, Inc. (TEM)

A side-by-side comparison of Bio-Rad Laboratories, Inc. and Tempus AI, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total returnBIO vs TEM

growth of $100 · dividends reinvested · last 2y
BIO +11.6%TEM +6.6%BIO compounded faster
50100150200250Start $10020252026$112$107
BIO TEM

BIO vs TEM: by the numbers

  • BIO is the larger company ($8.95B vs $7.51B market cap).
  • BIO is profitable (6.52% net margin) while TEM runs a net loss (-22.20%).
  • TEM grew revenue faster over the past five years (42.06% vs 0.29% CAGR).

Metrics side by side

Valuation

MetricBIOTEM
P/E ratio52.13N/A
Forward P/E35.00N/A
P/S ratio3.295.63
P/B ratio1.2418.44
EV / EBITDA21.48N/A
FCF yield4.19%N/A

Profitability

MetricBIOTEM
Gross margin51.87%69.55%
Operating margin9.25%-18.13%
Net margin6.52%-22.20%
ROE2.46%-72.74%
ROIC2.04%-10.29%

Growth (annualized)

MetricBIOTEM
Revenue CAGR (5Y)0.29%42.06%
EPS CAGR (5Y)-26.27%N/A
FCF CAGR (5Y)-7.57%N/A
Total return CAGR (5Y)-13.99%N/A

Frequently asked

Which has grown faster, BIO or TEM?
Over the past five years, TEM grew revenue faster — BIO at a 0.29% CAGR versus TEM at 42.06%.
Is BIO or TEM more profitable?
BIO runs the higher net margin — BIO at 6.52% versus TEM at -22.20%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.